glutamine has been researched along with alpha-Galactosidase A Deficiency in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bembi, B; Cariati, R; Ciana, G; Dominissini, S; Guerci, V; Nevyjel, M; Pittis, MG | 1 |
| Roth, J; Yam, GH; Zuber, C | 1 |
| Ishii, S; Kase, R; Sakuraba, H; Suzuki, Y | 1 |
3 other study(ies) available for glutamine and alpha-Galactosidase A Deficiency
| Article | Year |
|---|---|
Comparative in vitro expression study of four Fabry disease causing mutations at glutamine 279 of the alpha-galactosidase A protein.
Topics: alpha-Galactosidase; Animals; Blotting, Western; Chlorocebus aethiops; COS Cells; DNA Primers; Fabry Disease; Gene Expression; Glutamine; Humans; Infant; Lymphocytes; Male; Mutation, Missense; Sequence Analysis, DNA; Transfection | 2004 |
A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder.
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Amino Acid Substitution; Animals; Arginine; Cells, Cultured; Fabry Disease; Fibroblasts; Glutamine; Humans; Lysosomes; Mice; Mice, Transgenic; Molecular Chaperones; Mutation; Phenotype; Protein Binding; Protein Folding; Protein Transport; Trihexosylceramides | 2005 |
Characterization of a mutant alpha-galactosidase gene product for the late-onset cardiac form of Fabry disease.
Topics: Age of Onset; alpha-Galactosidase; Amino Acid Sequence; Animals; Cell Line; Enzyme Stability; Fabry Disease; Galactose; Gene Expression; Genetic Variation; Glutamates; Glutamic Acid; Glutamine; Humans; Hydrogen-Ion Concentration; Kinetics; Lymphocytes; Melibiose; Point Mutation; Recombinant Proteins; Thermodynamics; Transfection | 1993 |